What is the fair value of BNB Plus Corp (OTC-BNBX) stock?

The current fair value estimate for BNB Plus Corp (OTC-BNBX) is $0.23. This implies an estimated upside of 67.7% versus the current market price.

Is BNB Plus Corp (OTC-BNBX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 67.7% versus the current market price.

How is the financial health of BNB Plus Corp?

The current financial health read for BNB Plus Corp (OTC-BNBX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is BNB Plus Corp's next earnings date?

The next earnings date currently listed for BNB Plus Corp (OTC-BNBX) is December 17, 2026.

Does BNB Plus Corp (OTC-BNBX) pay dividends?

The latest available data indicates no current dividend yield for BNB Plus Corp (OTC-BNBX).

What is the market capitalization of BNB Plus Corp?

The current market capitalization listed for BNB Plus Corp is 842.822 K.

What is the enterprise value of BNB Plus Corp?

The current enterprise value listed for BNB Plus Corp is -3.195 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for BNB Plus Corp?

The ticker symbol for BNB Plus Corp is OTC-BNBX, and the stock is listed on OTC Markets.

Where is BNB Plus Corp (OTC-BNBX) listed?

BNB Plus Corp (OTC-BNBX) is listed on OTC Markets.

What is the debt-to-total-capital ratio for BNB Plus Corp?

The current debt-to-total-capital ratio listed for BNB Plus Corp is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for BNB Plus Corp?

The free float listed for BNB Plus Corp is 95.7%. Free float helps investors understand how much of the share base is available for public trading.

BNB Plus Corp (BNBX) Fair Value & Stock Analysis

BNB Plus Corp (BNBX)

BNB Plus Corp. is a common stock listing of a company with operations in digital asset treasury services and life sciences technologies. Through its subsidiaries, the company provides real-time tracking of treasury performance and market indicators, while also developing and commercializing technologies for the production and detection of DNA and RNA. Its life sciences activities include enzymatic manufacturing of synthetic DNA for nucleic acid-based therapeutics and solutions for the biopharmaceutical and diagnostics industries, along with products and technologies such as LineaDNA, LineaRNAP, and LineaIVT. The company also develops a proprietary RNAP used in mRNA therapeutics production. Formerly known as Applied DNA Sciences, Inc., the company adopted the BNB Plus Corp. name in November 2025. Founded in 1983, it is based in Stony Brook, New York, and its operations extend across the Americas, Europe, Asia, and other international markets.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-BNBX	$0.23	67.7% Upside	Bargain	Not available	Not available	Weak	0.0%	December 17, 2026	0.1x	0.4x	842.822 K	-3.195 M	0.0%	95.7%	-96.7	33.3%